This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Gurinder Atwal: Innovator in Mitochondrial DNA Quality Control
Introduction
Gurinder Atwal is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of biological sciences, particularly in the area of mitochondrial DNA quality control. His innovative work has the potential to enhance the reliability of biological samples used in various research and clinical applications.
Latest Patents
Gurinder Atwal holds 1 patent for his invention titled "Mitochondrial DNA quality control." This patent provides methods for identifying unreliable biological samples that may be mislabeled or contaminated. The invention focuses on determining the heteroplasmy and homoplasmy of mitochondrial DNA present in biological samples, which is crucial for ensuring the integrity of scientific research.
Career Highlights
Gurinder Atwal is currently employed at Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Regeneron has allowed him to apply his expertise in mitochondrial DNA to real-world challenges in the pharmaceutical industry.
Collaborations
Gurinder collaborates with talented colleagues, including Ruoyu Zhang and Wei Keat Lim. These collaborations foster a dynamic environment for innovation and contribute to the advancement of their shared goals in scientific research.
Conclusion
Gurinder Atwal's contributions to mitochondrial DNA quality control exemplify the impact of innovative thinking in the field of biological sciences. His work not only enhances the reliability of biological samples but also underscores the importance of collaboration in driving scientific progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
